The surface cholesteryl ester content of donor and acceptor particles regulates CETP: A liposome-based approach to assess the substrate properties of lipoproteins

Journal of Lipid Research

Volumn 44, Issue 7, 2003, Pages 1364-1372

  Morton, Richard E ^a   Greene, Diane J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cholesteryl ester transfer protein binding; Free cholesterol; Kinetics; Liposomes; Low density lipoprotein

Indexed keywords

CHOLESTEROL ESTER; CHOLESTEROL ESTER TRANSFER PROTEIN; LIPOPROTEIN; LIPOSOME; LOW DENSITY LIPOPROTEIN;

ARTICLE; KINETICS; LIPID TRANSPORT; LIPOPROTEIN BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; SURFACE PROPERTY;

BINDING SITES; CARDIOLIPINS; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL ESTERS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCOPROTEINS; HUMANS; KINETICS; LIPIDS; LIPOPROTEINS; LIPOPROTEINS, LDL; LIPOSOMES; SUBSTRATE SPECIFICITY;

EID: 0142105886     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300063-JLR200     Document Type: Article

References (61)

1. Morton, R. E. 1990. Interaction of lipid transfer protein with plasma lipoproteins and cell membranes. Experientia. 46: 552-560.
2. Tall, A. 1995. Plasma lipid transfer proteins. Annu. Rev. Biochem. 64: 235-257.
3. Zechner, R., H. Dieplinger, E. Steyrer, J. Groener, D. Calvert, and G. M. Kostner. 1987. In vitro formation of HDL-2 from HDL-3 and triacylglycerol-rich lipoproteins by the action of lecithin-cholesterol acyltransferase and cholesterol ester transfer protein. Biochim. Biophys. Acta. 918: 27-35.
4. Ellsworth, J. L., M. L. Kashyap, R. L. Jackson, and J. A. K. Harmony. 1987. Human plasma lipid transfer protein catalyzes the speciation of high density lipoproteins. Biochim. Biophys. Acta. 918: 260-266.
5. Deckelbaum, R. J., S. Eisenberg, Y. Oschry, E. Granot, I. Sharon, and G. Bengtsson-Olivecrona. 1986. Conversion of human plasma high density lipoprotein-2 to high density lipoprotein-3: roles of neutral lipid exchange and triglyceride lipases. J. Biol. Chem. 261: 5201-5208.
6. Tall, A. R. 1993. Plasma cholesteryl ester transfer protein. J. Lipid Res. 34: 1255-1274.
7. Morton, R. E. 1988. Interaction of plasma-derived lipid transfer protein with macrophages in culture. J. Lipid Res. 29: 1367-1377.
8. Skeggs, J. W., and R. E. Morton. 2002. LDL and HDL enriched in triglyceride promote abnormal cholesterol transport. J. Lipid Res. 43: 1264-1274.
9. Chait, A., S. Eisenberg, A. Steinmetz, J. J. Albers, and E. L. Bierman. 1984. Low-density lipoproteins modified by lipid transfer protein have altered biological activity. Biochim. Biophys. Acta. 795: 314-325.
10. Kinoshita, M., E. S. Krul, and G. Schonfeld. 1990. Modification of the core lipids of low density lipoproteins produces selective alterations in the expression of apoB-100 epitopes. J. Lipid Res. 31: 701-708.
11. Deckelbaum, R. J., S. Eisenberg, Y. Oschry, and L. L. Rudel. 1988. Neutral lipid transfer and lipolysis convert high molecular weight LDL from cholesterol-fed nonhuman primates towards normal: a molecular analysis. Biochim. Biophys. Acta. 961: 223-233.
12. Lagrost, L., P. Gambert, and C. Lallemant. 1994. Combined effects of lipid transfers and lipolysis on gradient gel patterns of human plasma LDL. Arterioscler. Thromb. 14: 1327-1336.
13. Viens, L., and L. Lagrost. 1997. Effect of lipid transfer activity and triglyceride hydrolysis on apolipoprotein B immunoreactivity in modified low density lipoproteins. J. Lipid Res. 38: 1129-1138.
14. Deckelbaum, R. J., S. Eisenberg, M. Fainaru, Y. Barenholz, and T. Olivecrona. 1979. In vitro production of human plasma low density lipoprotein-like particles: a model for very low density lipoprotein catabolism. J. Biol. Chem. 254: 6079-6087.
15. Barter, P. J., G. J. Hopkins, L. Gorjatschko, and M. E. Jones. 1982. A unified model of esterified cholesterol exchanges between human plasma lipoproteins. Atherosclerosis. 44: 27-40.
16. Ihm, J., D. M. Quinn, S. J. Busch, B. Chataing, and J. A. K. Harmony. 1982. Kinetics of plasma protein-catalyzed exchange of phosphatidylcholine and cholesteryl ester between plasma lipoproteins. J. Lipid Res. 23: 1328-1341.
17. Barter, P. J. 1991. Role of non-esterified fatty acids in regulating plasma cholesterol transport. Clin. Exp. Pharmacol. Physiol. 18: 77-79.
18. Weinberg, R. B., V. R. Cook, J. B. Jones, P. Kussie, and A. R. Tall. 1994. Interfacial properties of recombinant human cholesterol ester transfer protein. J. Biol. Chem. 269: 29588-29591.
19. Epps, D. E., K. A. Greenlee, J. S. Harris, E. W. Thomas, C. K. Castle, J. F. Fisher, R. R. Hozak, C. K. Marschke, G. W. Melchior, and F. J. Kézdy. 1995. Kinetics and inhibition of lipid exchange catalyzed by plasma cholesteryl ester transfer protein (lipid transfer protein). Biochemistry. 34: 12560-12569.
20. Connolly, D. T., J. McIntyre, D. Heuvelman, E. E. Remsen, R. E. McKinnie, L. Vu, M. Melton, R. Monsell, E. S. Krul, and K. Glenn. 1996. Physical and kinetic characterization of recombinant human cholesteryl ester transfer protein. Biochem. J. 320: 39-47.
21. Wang, S., P. Kussie, L. Deng, and A. Tall. 1995. Defective binding of neutral lipids by a carboxyl-terminal deletion mutant of cholesteryl ester transfer protein. Evidence for a carboxyl-terminal cholesteryl ester binding site essential for neutral lipid transfer activity. J. Biol. Chem. 270: 612-618.
22. Swenson, T. L., R. W. Brocia, and A. R. Tall. 1988. Plasma cholesteryl ester transfer protein has binding sites for neutral lipids and phospholipids. J. Biol. Chem. 263: 5150-5157.
23. Morton, R. E. 1985. Binding of plasma-derived lipid transfer protein to lipoprotein substrates: the role of binding in the lipid transfer process. J. Biol. Chem. 260: 12593-12599.
24. Pattnaik, N. M., and D. B. Zilversmit. 1979. Interaction of cholesteryl ester exchange protein with human plasma lipoproteins and phospholipid vesicles. J. Biol. Chem. 254: 2782-2786.
25. Sammett, D., and A. R. Tall. 1985. Mechanisms of enhancement of cholesteryl ester transfer protein activity by lipolysis. J. Biol. Chem. 260: 6687-6697.
26. Wang, S., L. Deng, M. L. Brown, L. B. Agellon, and A. R. Tall. 1991. Structure-function studies of human cholesteryl ester transfer protein by linker insertion scanning mutagenesis. Biochemistry. 30: 3484-3490.
27. Morton, R. E., and D. B. Zilversmit. 1983. Inter-relationship of lipids transferred by the lipid-transfer protein isolated from human lipoprotein-deficient plasma. J. Biol. Chem. 258: 11751-11757.
28. Ko, K. W. S., T. Ohnishi, and S. Yokoyama. 1994. Triglyceride transfer is required for net cholesteryl ester transfer between lipoproteins in plasma by lipid transfer protein. Evidence for a hetero-exchange transfer mechanism demonstrated by using novel monoclonal antibodies. J. Biol. Chem. 269: 28206-28213.
29. Serdyuk, A. P., and R. E. Morton. 1997. Lipid transfer inhibitor protein activity deficiency in normolipidemic uremic patients on continuous ambulatory peritoneal dialysis. Arterioscler. Thromb. Vasc. Biol. 17: 1716-1724.
30. Serdyuk, A. P., and R. E. Morton. 1999. Lipid transfer inhibitor protein defines the participation of lipoproteins in lipid transfer reactions: CETP has no preference for cholesteryl esters in HDL versus LDL. Arterioscler. Thromb. Vasc. Biol. 19: 718-726.
31. Van Tol, A., L. M. Scheek, and J. E. M. Groener. 1991. Net mass transfer of cholesteryl esters from low density lipoproteins to high density lipoproteins in plasma from normolipidemic subjects. Arterioscler. Thromb. 11: 55-63.
32. Yen, F. T., R. J. Deckelbaum, C. J. Mann, Y. L. Marcel, R. W. Milne, and A. R. Tall. 1989. Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody. Effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma. J. Clin. Invest. 83: 2018-2024.
33. Liu, X. Q., and J. D. Bagdade. 1995. Neutral lipid mass transfer among lipoproteins in plasma from normolipidemic subjects is not an equimolar heteroexchange. J. Lipid Res. 36: 2574-2579.
34. Morton, R. E., and J. V. Steinbrunner. 1990. Concentration of neutral lipids in the phospholipid surface of substrate particles determines lipid transfer protein activity. J. Lipid Res. 31: 1559-1567.
35. Bruce, C., W. S. Davidson, P. Kussie, S. Lund-Katz, M. C. Phillips, R. Ghosh, and A. R. Tall. 1995. Molecular determinants of plasma cholesteryl ester transfer protein binding to high density lipoproteins. J. Biol. Chem. 270: 11532-11542.
36. Morton, R. E., and D. B. Zilversmit. 1982. Purification and characterization of lipid transfer protein(s) from human lipoprotein-deficient plasma. J. Lipid Res. 23: 1058-1067.
37. Pattnaik, N. M., A. Montes, L. B. Hughes, and D. B. Zilversmit. 1978. Cholesteryl ester exchange protein in human plasma: isolation and characterization. Biochim. Biophys. Acta. 530: 428-438.
38. Morton, R. E., and D. B. Zilversmit. 1981. The separation of apolipoprotein D from cholesteryl ester transfer protein. Biochim. Biophys. Acta. 663: 350-355.
39. Austin, M. A., J. L. Breslow, C. H. Hennekens, J. E. Buring, W. C. Willet, and R. M. Krauss. 1988. Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 260: 1917-1921.
40. Jarnagin, A. S., W. Kohr, and C. Fielding. 1987. Isolation and specificity of a Mr 74,000 cholesteryl ester transfer protein from human plasma. Proc. Natl. Acad. Sci. USA. 84: 1854-1857.
41. Nishida, H. I., H. Arai, and T. Nishida. 1993. Cholesterol ester transfer mediated by lipid transfer protein as influenced by changes in the charge characteristics of plasma lipoproteins. J. Biol. Chem. 268: 16352-16360.
42. Havel, R. J., H. A. Eder, and J. H. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
43. Morton, R. E., and D. B. Zilversmit. 1981. A plasma inhibitor of triglyceride and cholesteryl ester transfer activities. J. Biol. Chem. 256: 11992-11995.
44. Morton, R. E. 1988. Free cholesterol is a potent regulator of lipid transfer protein function. J. Biol. Chem. 263: 12235-12241.
45. Brunner, J., P. Skrabal, and H. Hauser. 1976. Single bilayer vesicles prepared without sonication: physico-chemical properties. Biochim. Biophys. Acta. 455: 322-331.
46. Lagrost, L., A. Athias, P. Gambert, and C. Lallemant. 1994. Comparative study of phospholipid transfer activities mediated by cholesteryl ester transfer protein and phospholipid transfer protein. J. Lipid Res. 35: 825-835.
47. Morton, R. E., and J. S. Parks. 1996. Plasma cholesteryl ester transfer activity is modulated by the phase transition of the lipoprotein core. J. Lipid Res. 37: 1915-1923.
48. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
49. Peterson, G. L. 1977. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 83: 346-356.
50. Zak, B., N. Moss, A. J. Boyle, and A. Zlatkis. 1954. Reactions of certain unsaturated steroids with acid iron reagent. Anal. Chem. 26: 776-777.
51. Bartlett, G. R. 1959. Phosphorus assay in column chromatography. J. Biol. Chem. 234: 466-468.
52. Miller, K. W., and D. M. Small. 1983. Triolein-cholesteryl oleate-cholesterol-lecithin emulsions: structural models of triglyceride-rich lipoproteins. Biochemistry. 22: 443-451.
53. Miller, K. W., and D. M. Small. 1982. The phase behavior of triolein, cholesterol, and lecithin emulsions. J. Colloid Interface. Sci. 89: 466-478.
54. Fielding, C. J. 1984. The origin and properties of free cholesterol potential gradients in plasma, and their relation to atherogenesis. J. Lipid Res. 25: 1624-1628.
55. Fielding, C. J., G. M. Reaven, G. Liu, and P. E. Fielding. 1984. Increased free cholesterol in plasma low and very low density lipoproteins in non-insulin-dependent diabetes mellitus: its role in the inhibition of cholesteryl ester transfer. Proc. Natl. Acad. Sci. USA. 81: 2512-2516.
56. Bagdade, J. D., E. Helve, and M. R. Taskinen. 1991. Effects of continuous insulin infusion therapy on lipoprotein surface and core lipid composition in insulin-dependent diabetes mellitus. Metabolism. 40: 445-449.
57. Mann, C. J., F. T. Yen, A. M. Grant, and B. E. Bihain. 1991. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J. Clin. Invest. 88: 2059-2066.
58. Murakami, T., S. Michelagnoli, R. Longhi, G. Gianfranceschi, F. Pazzucconi, L. Calabresi, C. R. Sirtori, and G. Franceschini. 1995. Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma. Arterioscler. Thromb. Vasc. Biol. 15: 1819-1828.
59. Bagdade, J. D., D. Kaufman, M. C. Ritter, and P. V. Subbaiah. 1990. Probucol treatment in hypercholesterolemic patients: effects on lipoprotein composition, HDL particle size, and cholesteryl ester transfer. Atherosclerosis. 84: 145-154.
60. Bagdade, J. D., J. T. Lane, P. V. Subbaiah, M. E. Otto, and M. C. Ritter. 1993. Accelerated cholesteryl ester transfer in noninsulin-dependent diabetes mellitus. Atherosclerosis. 104: 69-77.
61. Bagdade, J. D., M. C. Ritter, and P. V. Subbaiah. 1991. Accelerated cholesteryl ester transfer in patients with insulin-dependent diabetes mellitus. Eur. J. Clin. Invest. 21: 161-167.